These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9576133)

  • 21. Comparison of nurse- and physician-determined clinic blood pressure levels in patients referred to a hypertension clinic: implications for subsequent management.
    La Batide-Alanore A; Chatellier G; Bobrie G; Fofol I; Plouin PF
    J Hypertens; 2000 Apr; 18(4):391-8. PubMed ID: 10779088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ["White-coat hypertension": variation of normality or of hypertension?].
    Carmona J; Amado P; Vasconcelos N; Santos I; Pinto C; Forte G; Arsénio A; Nazaré J
    Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of white-coat response in patients with treated hypertension.
    MacDonald MB; Laing GP; Wilson MP; Wilson TW
    CMAJ; 1999 Aug; 161(3):265-9. PubMed ID: 10463047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular systolic and diastolic function assessed with two-dimensional and doppler echocardiography in "white coat" hypertension.
    Soma J; Widerøe TE; Dahl K; Rossvoll O; Skjaerpe T
    J Am Coll Cardiol; 1996 Jul; 28(1):190-6. PubMed ID: 8752813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White coat effect in treated and untreated patients with high office blood pressure. Relationship with pulse wave velocity and left ventricular mass index.
    Silveira A; Mesquita A; Maldonado J; Silva JA; Polónia J
    Rev Port Cardiol; 2002 May; 21(5):517-30. PubMed ID: 12174516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experience with noninvasive ambulatory 24-hour blood pressure recording in a community hospital.
    van de Weijgert EJ; Braun JJ
    Neth J Med; 1992 Apr; 40(3-4):175-82. PubMed ID: 1603208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is the value of home (self) blood pressure monitoring in patients with hypertensive heart disease?
    Mengden T; Schwartzkopff B; Strauer BE
    Am J Hypertens; 1998 Jul; 11(7):813-9. PubMed ID: 9683042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In the aftermath of SPRINT: further comparison of unattended automated office blood pressure measurement and 24-hour blood pressure monitoring.
    Seidlerová J; Gelžinský J; Mateřánková M; Ceral J; König P; Filipovský J
    Blood Press; 2018 Oct; 27(5):256-261. PubMed ID: 29566565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physiological, psychological, and behavioral factors and white coat hypertension.
    Siegel WC; Blumenthal JA; Divine GW
    Hypertension; 1990 Aug; 16(2):140-6. PubMed ID: 2379947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detecting white coat and reverse white coat effects in clinic settings using measures of blood pressure habituation in the clinic and patient self-monitoring of blood pressure.
    Larkin KT; Schauss SL; Elnicki DM; Goodie JL
    J Hum Hypertens; 2007 Jul; 21(7):516-24. PubMed ID: 17361194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors for the white coat effect in general practice patients with suspected and treated hypertension.
    Lindbaek M; Sandvik E; Liodden K; Mjell J; Ravnsborg-Gjertsen K
    Br J Gen Pract; 2003 Oct; 53(495):790-3. PubMed ID: 14601355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of white coat effect in treated hypertensive patients in the community.
    Myers MG; Oh PI; Reeves RA; Joyner CD
    Am J Hypertens; 1995 Jun; 8(6):591-7. PubMed ID: 7662244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. White-coat resistant hypertension.
    Mezzetti A; Pierdomenico SD; Costantini F; Romano F; Bucci A; Di Gioacchino M; Cuccurullo F
    Am J Hypertens; 1997 Nov; 10(11):1302-7. PubMed ID: 9397251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory blood pressure: normality and comparison with other measurements. Hypertension Working Group.
    Schettini C; Bianchi M; Nieto F; Sandoya E; Senra H
    Hypertension; 1999 Oct; 34(4 Pt 2):818-25. PubMed ID: 10523367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population.
    Sega R; Cesana G; Milesi C; Grassi G; Zanchetti A; Mancia G
    Hypertension; 1997 Jul; 30(1 Pt 1):1-6. PubMed ID: 9231813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How common is white coat hypertension?
    Pickering TG; James GD; Boddie C; Harshfield GA; Blank S; Laragh JH
    JAMA; 1988 Jan; 259(2):225-8. PubMed ID: 3336140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-pressure control in the hypertensive population.
    Mancia G; Sega R; Milesi C; Cesana G; Zanchetti A
    Lancet; 1997 Feb; 349(9050):454-7. PubMed ID: 9040574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy.
    Nielsen FS; Gaede P; Vedel P; Pedersen O; Parving HH
    Diabetes Care; 1997 May; 20(5):859-63. PubMed ID: 9135956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anxiety and outcome expectations predict the white-coat effect.
    Jhalani J; Goyal T; Clemow L; Schwartz JE; Pickering TG; Gerin W
    Blood Press Monit; 2005 Dec; 10(6):317-9. PubMed ID: 16496447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the white coat effect.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Porcellati C
    Hypertension; 1997 Jun; 29(6):1218-24. PubMed ID: 9180621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.